COVID-19 in pediatric survivors of childhood cancer and hematopoietic cell transplantation from a single center in New York City.

Abstract

Childhood cancer survivors are at increased risk for treatment‐related late effects; data are lacking on how coronavirus disease 2019 (COVID‐19) infection impacts this cohort. We assessed COVID‐19‐related symptoms, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) IgG seroprevalence, and rate of COVID‐19‐related hospitalization among 321 asymptomatic survivors of childhood cancer or transplantation seen for routine long‐term follow‐up between May and September 2020 in a New York City tertiary cancer center. While 10.9% (n = 35) reported possible COVID‐19‐related symptoms, 7.8% (n = 20) of those tested had positive SARS‐CoV‐2 IgG, and one patient (0.3%) required COVID‐19‐related hospitalization. This report suggests that childhood cancer survivors appear to be at relatively low risk for COVID‐19 complications.